Community/Retail

A United States District Court judge in Delaware granted Amgen's request for a permanent injunction prohibiting Sanofi/Regeneron from manufacturing, using, selling or offering their monoclonal antibodies to proprotein convertase subtilisin/kexin type 9 (PCSK9).

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.